Skip to main content
Journal cover image

Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials.

Publication ,  Journal Article
Shaikh, A; Ochani, RK; Khan, MS; Riaz, H; Khan, SU; Sreenivasan, J; Mookadam, F; Doukky, R; Butler, J; Michos, ED; Kalra, A; Krasuski, RA
Published in: Am Heart J
December 2020

UNLABELLED: Cardiovascular randomized controlled trials (RCTs) typically set composite end points as the primary outcome to enhance statistical power. However, influence of individual component end points on overall composite outcomes remains understudied. METHODS: We searched MEDLINE for RCTs published in 6 high-impact journals (The Lancet, the New England Journal of Medicine, Journal of the American Medical Association, Circulation, Journal of the American College of Cardiology and the European Heart Journal) from 2011 to 2017. Two-armed, parallel-design cardiovascular RCTs which reported composite outcomes were included. All-cause or cardiovascular mortality, myocardial infarction, heart failure, and stroke were deemed "hard" end points, whereas hospitalization, angina, and revascularization were identified as "soft" end points. Type of outcome (primary or secondary), event rates in treatment and control groups for the composite outcome and of its components according to predefined criteria. RESULTS: Of the 45.8% (316/689) cardiovascular RCTs which used a composite outcome, 79.4% set the composite as the primary outcome. Death was the most common component (89.8%) followed by myocardial infarction (66.1%). About 80% of the trials reported complete data for each component. One hundred forty-seven trials (46.5%) incorporated a "soft" end point as part of their composite. Death contributed the least to the estimate of effects (R2 change = 0.005) of the composite, whereas revascularization contributed the most (R2 change = 0.423). CONCLUSIONS: Cardiovascular RCTs frequently use composite end points, which include "soft" end points, as components in nearly 50% of studies. Higher event rates in composite end points may create a misleading interpretation of treatment impact due to large contributions from end points with less clinical significance.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

December 2020

Volume

230

Start / End Page

71 / 81

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Stroke
  • Risk
  • Randomized Controlled Trials as Topic
  • Periodicals as Topic
  • Myocardial Revascularization
  • Myocardial Infarction
  • Journal Impact Factor
  • Humans
  • Hospitalization
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shaikh, A., Ochani, R. K., Khan, M. S., Riaz, H., Khan, S. U., Sreenivasan, J., … Krasuski, R. A. (2020). Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials. Am Heart J, 230, 71–81. https://doi.org/10.1016/j.ahj.2020.09.001
Shaikh, Asim, Rohan Kumar Ochani, Muhammad Shahzeb Khan, Haris Riaz, Safi U. Khan, Jayakumar Sreenivasan, Farouk Mookadam, et al. “Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials.Am Heart J 230 (December 2020): 71–81. https://doi.org/10.1016/j.ahj.2020.09.001.
Shaikh A, Ochani RK, Khan MS, Riaz H, Khan SU, Sreenivasan J, et al. Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials. Am Heart J. 2020 Dec;230:71–81.
Shaikh, Asim, et al. “Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials.Am Heart J, vol. 230, Dec. 2020, pp. 71–81. Pubmed, doi:10.1016/j.ahj.2020.09.001.
Shaikh A, Ochani RK, Khan MS, Riaz H, Khan SU, Sreenivasan J, Mookadam F, Doukky R, Butler J, Michos ED, Kalra A, Krasuski RA. Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials. Am Heart J. 2020 Dec;230:71–81.
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

December 2020

Volume

230

Start / End Page

71 / 81

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Stroke
  • Risk
  • Randomized Controlled Trials as Topic
  • Periodicals as Topic
  • Myocardial Revascularization
  • Myocardial Infarction
  • Journal Impact Factor
  • Humans
  • Hospitalization